0.019956
0.011522
0.000000
0.000000
0.023044
0.000000
0.000000
0.000000
0.021219
0.00000
0.00000
0.00000
Johansson, K.
Bourhis, J.-M.
Campanacci, V.
Cambillau, C.
Canard, B.
Longhi, S.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
6
90.00
90.00
120.00
50.109
50.109
47.127
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C5 H11 N O2 Se
196.106
n
SELENOMETHIONINE
L-peptide linking
C8 H17 N O3 S
207.290
2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID
N-CYCLOHEXYLTAURINE; CHES
non-polymer
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
278
44567
10.1074/JBC.M308745200
12944395
Crystal Structure of the Measles Virus Phosphoprotein Domain Responsible for the Induced Folding of the C-Terminal Domain of the Nucleoprotein
2003
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100.0
1
CCD
2003-06-13
ADSC CCD
SINGLE WAVELENGTH
M
x-ray
1
0.933
1.0
ID14-2
ESRF
0.933
SYNCHROTRON
ESRF BEAMLINE ID14-2
6892.544
RNA POLYMERASE ALPHA SUBUNIT
2.7.7.48
XD-DOMAIN, RESIDUES 459-507
1
man
polymer
207.290
2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID
1
syn
non-polymer
18.015
water
64
nat
water
PHOSPHOPROTEIN, NUCLEOCAPSID PHOSPHOPROTEIN
no
yes
(MSE)ASRSVIRSIIKSSRLEEDRKRYL(MSE)TLLDDIKGANDLAKFHQ(MSE)LVKII(MSE)KHHHHHH
MASRSVIRSIIKSSRLEEDRKRYLMTLLDDIKGANDLAKFHQMLVKIIMKHHHHHH
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
EDMONSTON B
sample
SELENOMETHIONINE
11234
MEASLES VIRUS
562
ESCHERICHIA COLI
C41[DE3]PLYSS
PDEST14
1
2.36
47.5
8.50
0.1 M CHES PH 8.5, 1.25 M NA CITRATE
repository
Initial release
Version format compliance
Version format compliance
1
0
2003-09-01
1
1
2011-05-08
1
2
2011-07-13
PDBE
Y
PDBE
2003-07-29
REL
1
A
O
HOH
2011
7.26
NHE
2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID
HOH
water
CATALYTIC ACTIVITY: N NUCLEOSIDE TRIPHOSPHATE =
N DIPHOSPHATE + {RNA}(N).
THIS CONFLICT IS DUE TO THE FACT THAT THE P GENE USED AS
TEMPLATE TO AMPLIFY THE MEASLES VIRUS PHOSPHOPROTEIN XD
GENE FRAGMENT IS THE PLASMID PSC6/P (RADECKE ET AL. EMBO,
1995) WHICH CONTAINS THIS MUTATION. HOWEVER, THIS MUTATED
PHOSPHOPROTEIN IS FUNCTIONAL, AS INDICATED BY THE FACT THAT
IT ALLOWS RESCUE OF MEASLES VIRUS IN A REVERSE GENETICS
SYSTEM.
NHE
1055
2
NHE
NHE
1055
A
HOH
2001
3
HOH
HOH
2001
A
HOH
2002
3
HOH
HOH
2002
A
HOH
2003
3
HOH
HOH
2003
A
HOH
2004
3
HOH
HOH
2004
A
HOH
2005
3
HOH
HOH
2005
A
HOH
2006
3
HOH
HOH
2006
A
HOH
2007
3
HOH
HOH
2007
A
HOH
2008
3
HOH
HOH
2008
A
HOH
2009
3
HOH
HOH
2009
A
HOH
2010
3
HOH
HOH
2010
A
HOH
2011
3
HOH
HOH
2011
A
HOH
2012
3
HOH
HOH
2012
A
HOH
2013
3
HOH
HOH
2013
A
HOH
2014
3
HOH
HOH
2014
A
HOH
2015
3
HOH
HOH
2015
A
HOH
2016
3
HOH
HOH
2016
A
HOH
2017
3
HOH
HOH
2017
A
HOH
2018
3
HOH
HOH
2018
A
HOH
2019
3
HOH
HOH
2019
A
HOH
2020
3
HOH
HOH
2020
A
HOH
2021
3
HOH
HOH
2021
A
HOH
2022
3
HOH
HOH
2022
A
HOH
2023
3
HOH
HOH
2023
A
HOH
2024
3
HOH
HOH
2024
A
HOH
2025
3
HOH
HOH
2025
A
HOH
2026
3
HOH
HOH
2026
A
HOH
2027
3
HOH
HOH
2027
A
HOH
2028
3
HOH
HOH
2028
A
HOH
2029
3
HOH
HOH
2029
A
HOH
2030
3
HOH
HOH
2030
A
HOH
2031
3
HOH
HOH
2031
A
HOH
2032
3
HOH
HOH
2032
A
HOH
2033
3
HOH
HOH
2033
A
HOH
2034
3
HOH
HOH
2034
A
HOH
2035
3
HOH
HOH
2035
A
HOH
2036
3
HOH
HOH
2036
A
HOH
2037
3
HOH
HOH
2037
A
HOH
2038
3
HOH
HOH
2038
A
HOH
2039
3
HOH
HOH
2039
A
HOH
2040
3
HOH
HOH
2040
A
HOH
2041
3
HOH
HOH
2041
A
HOH
2042
3
HOH
HOH
2042
A
HOH
2043
3
HOH
HOH
2043
A
HOH
2044
3
HOH
HOH
2044
A
HOH
2045
3
HOH
HOH
2045
A
HOH
2046
3
HOH
HOH
2046
A
HOH
2047
3
HOH
HOH
2047
A
HOH
2048
3
HOH
HOH
2048
A
HOH
2049
3
HOH
HOH
2049
A
HOH
2050
3
HOH
HOH
2050
A
HOH
2051
3
HOH
HOH
2051
A
HOH
2052
3
HOH
HOH
2052
A
HOH
2053
3
HOH
HOH
2053
A
HOH
2054
3
HOH
HOH
2054
A
HOH
2055
3
HOH
HOH
2055
A
HOH
2056
3
HOH
HOH
2056
A
HOH
2057
3
HOH
HOH
2057
A
HOH
2058
3
HOH
HOH
2058
A
HOH
2059
3
HOH
HOH
2059
A
HOH
2060
3
HOH
HOH
2060
A
HOH
2061
3
HOH
HOH
2061
A
HOH
2062
3
HOH
HOH
2062
A
HOH
2063
3
HOH
HOH
2063
A
HOH
2064
3
HOH
HOH
2064
A
n
1
1
A
ALA
2
n
2
ALA
2
A
SER
3
n
3
SER
3
A
ARG
4
n
4
ARG
4
A
SER
5
n
5
SER
5
A
VAL
6
n
6
VAL
6
A
ILE
7
n
7
ILE
7
A
ARG
8
n
8
ARG
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
ILE
11
n
11
ILE
11
A
LYS
12
n
12
LYS
12
A
SER
13
n
13
SER
13
A
SER
14
n
14
SER
14
A
ARG
15
n
15
ARG
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
GLU
18
n
18
GLU
18
A
ASP
19
n
19
ASP
19
A
ARG
20
n
20
ARG
20
A
LYS
21
n
21
LYS
21
A
ARG
22
n
22
ARG
22
A
TYR
23
n
23
TYR
23
A
LEU
24
n
24
LEU
24
A
MSE
25
n
25
MSE
25
A
THR
26
n
26
THR
26
A
LEU
27
n
27
LEU
27
A
LEU
28
n
28
LEU
28
A
ASP
29
n
29
ASP
29
A
ASP
30
n
30
ASP
30
A
ILE
31
n
31
ILE
31
A
LYS
32
n
32
LYS
32
A
GLY
33
n
33
GLY
33
A
ALA
34
n
34
ALA
34
A
ASN
35
n
35
ASN
35
A
ASP
36
n
36
ASP
36
A
LEU
37
n
37
LEU
37
A
ALA
38
n
38
ALA
38
A
LYS
39
n
39
LYS
39
A
PHE
40
n
40
PHE
40
A
HIS
41
n
41
HIS
41
A
GLN
42
n
42
GLN
42
A
MSE
43
n
43
MSE
43
A
LEU
44
n
44
LEU
44
A
VAL
45
n
45
VAL
45
A
LYS
46
n
46
LYS
46
A
ILE
47
n
47
ILE
47
A
ILE
48
n
48
ILE
48
A
MSE
49
n
49
MSE
49
A
LYS
50
n
50
LYS
50
A
HIS
51
n
51
HIS
51
A
HIS
52
n
52
HIS
52
A
HIS
53
n
53
HIS
53
A
HIS
54
n
54
HIS
54
A
HIS
55
n
55
HIS
55
A
n
56
56
A
author_and_software_defined_assembly
PQS
1
monomeric
A
MSE
25
SELENOMETHIONINE
A
MSE
25
MET
A
MSE
43
SELENOMETHIONINE
A
MSE
43
MET
A
MSE
49
SELENOMETHIONINE
A
MSE
49
MET
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
CA
HIS
55
A
CA
HIS
55
1
Y
1
A
C
HIS
55
A
C
HIS
55
1
Y
1
A
O
HIS
55
A
O
HIS
55
1
Y
1
A
CB
HIS
55
A
CB
HIS
55
1
Y
1
A
CG
HIS
55
A
CG
HIS
55
1
Y
1
A
ND1
HIS
55
A
ND1
HIS
55
1
Y
1
A
CD2
HIS
55
A
CD2
HIS
55
1
Y
1
A
CE1
HIS
55
A
CE1
HIS
55
1
Y
1
A
NE2
HIS
55
A
NE2
HIS
55
1
Y
1
A
MSE
1
A
MSE
1
1
Y
1
A
HIS
56
A
HIS
56
1
Y
1
A
A
SE
CE
MSE
MSE
25
25
-0.380
0.059
1.950
1.570
N
35.76
1.34000
0.67000
0.00000
1.34000
0.00000
-2.01000
0.961
0.949
0.239
0.198
0.200
1.80
12.00
310
6291
4.700
99.8
3.323
0.099
RANDOM
1
THROUGHOUT
SIRAS
0.127
0.126
0.80
0.80
1.40
MAXIMUM LIKELIHOOD
BABINET MODEL WITH MASK
1.80
12.00
64
517
13
0
440
0.024
0.021
459
1.502
1.980
609
4.483
5.000
52
0.010
0.020
321
0.226
0.200
216
0.181
0.200
30
0.153
0.200
21
0.200
0.200
15
1.857
1.500
266
3.207
2.000
428
5.632
3.000
193
7.899
4.500
181
0.3650
0.2840
1.85
23
458
20
1.800
12.000
1OKS
6611
0.05200
1
6.5000
6.800
99.6
0.47200
1.80
1.90
1.600
1
6.90
100.0
refinement
REFMAC
5.1.24
data reduction
MOSFLM
data scaling
SCALA
RNA POLYMERASE ALPHA SUBUNIT (E.C.2.7.7.48)
Crystal structure of the measles virus phosphoprotein XD domain
1
N
N
2
N
N
3
N
N
A
SER
3
A
SER
3
HELX_P
A
SER
14
A
SER
14
1
1
12
A
GLU
17
A
GLU
17
HELX_P
A
ILE
31
A
ILE
31
1
2
15
A
GLY
33
A
GLY
33
HELX_P
A
GLN
42
A
GLN
42
1
3
10
A
LEU
44
A
LEU
44
HELX_P
A
HIS
53
A
HIS
53
1
4
10
covale
1.327
A
LEU
24
A
C
LEU
24
1_555
A
MSE
25
A
N
MSE
25
1_555
covale
1.339
A
MSE
25
A
C
MSE
25
1_555
A
THR
26
A
N
THR
26
1_555
covale
1.339
A
GLN
42
A
C
GLN
42
1_555
A
MSE
43
A
N
MSE
43
1_555
covale
1.330
A
MSE
43
A
C
MSE
43
1_555
A
LEU
44
A
N
LEU
44
1_555
covale
1.326
A
ILE
48
A
C
ILE
48
1_555
A
MSE
49
A
N
MSE
49
1_555
covale
1.328
A
MSE
49
A
C
MSE
49
1_555
A
LYS
50
A
N
LYS
50
1_555
TRANSFERASE
TRANSFERASE, RNA-DIRECTED RNA POLYMERASE, NUCLEOCAPSID, PHOSPHORYLATION.
1OKS
PDB
1
1OKS
P03422
UNP
1
P03422
1
1
1OKS
1
1
1OKS
A
1
1
1
459
507
1OKS
2
50
P03422
A
2
2
50
51
56
1OKS
51
56
1OKS
A
1
51
56
1
MET
conflict
VAL
45
1OKS
A
P03422
UNP
502
45
BINDING SITE FOR RESIDUE NHE A1055
Software
8
A
ARG
20
A
ARG
20
8
1_555
A
TYR
23
A
TYR
23
8
1_555
A
HIS
41
A
HIS
41
8
1_555
A
VAL
45
A
VAL
45
8
1_555
A
ILE
47
A
ILE
47
8
1_555
A
HIS
51
A
HIS
51
8
1_555
A
HOH
2031
C
HOH
8
1_555
A
HOH
2064
C
HOH
8
1_555
154
P 32 2 1